Owen A O’Connor, MD, PhD from the Columbia University Medical Center Center for Lymphoid Malignancies, New York, NY, talks about the progress in treating Hodgkin lymphoma (HL) and how this might translate into better outcomes for HL patients in light of some studies presented at the American Society of Hematology (ASH) 2015 Annual Meeting in Orlando, FL.